Walleye Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,500
| Closed | -$410K | – | 2503 |
|
|
2024
Q2 | $410K | Buy |
+1,500
| New | +$410K | ﹤0.01% | 1533 |
|
|
2024
Q1 | – | Sell |
-1,281
| Closed | -$414K | – | 2651 |
|
|
2023
Q4 | $414K | Buy |
+1,281
| New | +$414K | ﹤0.01% | 1224 |
|
|
2023
Q1 | – | Sell |
-3,330
| Closed | -$1.4M | – | 2165 |
|
|
2022
Q4 | $1.4M | Sell |
3,330
-7,564
| -69% | -$3.18M | 0.03% | 582 |
|
|
2022
Q3 | $4.54M | Buy |
10,894
+8,233
| +309% | +$3.43M | 0.09% | 234 |
|
|
2022
Q2 | $1.32M | Sell |
2,661
-5,983
| -69% | -$2.96M | 0.04% | 500 |
|
|
2022
Q1 | $4.87M | Buy |
8,644
+7,600
| +728% | +$4.28M | 0.13% | 159 |
|
|
2021
Q4 | $789K | Buy |
1,044
+280
| +37% | +$212K | 0.02% | 704 |
|
|
2021
Q3 | $570 | Buy |
+764
| New | +$570 | 0.02% | 710 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 554 |
|
|
2019
Q4 | – | Sell |
-10
| Closed | -$3K | – | 687 |
|
|
2019
Q3 | $3K | Sell |
10
-20
| -67% | -$6K | ﹤0.01% | 458 |
|
|
2019
Q2 | $9K | Buy |
+30
| New | +$9K | ﹤0.01% | 432 |
|